Anders D. Hove, Director at Edge Therapeutics, Inc. (EDGE), bought 2,068,582 shares at $11.00 ($5.4M) on 2015-10-06, disclosed to the SEC on 2015-10-08.
Open-market purchase of $5.4M EDGE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,571,917 | $0 | 0.0% |
| 2 | $8.60 | 46,665 | $401K | 7.5% |
| 3 | $11.00 | 450,000 | $5.0M | 92.5% |
| Total | $2.59 avg | 2,068,582 | $5.4M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |